About DermaFlow

About company

DermaFlow develops a non-invasive proprietary technology to monitor and stimulate the peripheral blood flow. It peripheral blood flow monitoring technology provides clinicians and consumers with the opportunity of user-friendly, non-invasive, and accurate monitoring of the dermal microcirculation, and brings the next vital sign in the assessment of acute and chronic disease states. DermaFlow was founded on 2010 and is headquartered in Cherry Hill, New Jersey.